NATCO Pharma Limited (NSE:NATCOPHARM)

NATCO Pharma Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	43,958	44,295	39,988	27,071	19,448	20,521
Other Revenue	136	-	32	14	14	40
Revenue	44,094	44,295	40,020	27,085	19,462	20,561
Revenue Growth (YoY)	1.39%	10.68%	47.76%	39.17%	-5.34%	7.37%
Cost of Revenue	7,426	6,898	7,487	6,544	5,845	5,318
Gross Profit	36,668	37,397	32,533	20,541	13,617	15,243
Selling, General & Admin	6,215	5,945	5,309	4,625	4,806	4,390
Other Operating Expenses	10,695	9,492	9,599	6,072	5,952	4,634
Operating Expenses	19,397	17,789	16,827	12,443	12,383	10,310
Operating Income	17,271	19,608	15,706	8,098	1,234	4,933
Interest Expense	-219	-239	-203	-148	-132	-93
Interest & Investment Income	-	-	1,013	513	392	566
Currency Exchange Gain (Loss)	-	-	103	214	103	40
Other Non Operating Income (Expenses)	3,545	3,545	97	130	-3	30
EBT Excluding Unusual Items	20,597	22,914	16,716	8,807	1,594	5,476
Merger & Restructuring Charges	-	-	-	-291	-11	-
Gain (Loss) on Sale of Investments	-	-	-7	-52	12	-
Gain (Loss) on Sale of Assets	-	-	-17	178	427	320
Asset Writedown	-	-	-	-23	-	-
Pretax Income	20,597	22,914	16,735	8,619	2,022	5,796
Income Tax Expense	3,645	4,080	2,852	1,466	322	1,372
Earnings From Continuing Operations	16,952	18,834	13,883	7,153	1,700	4,424
Net Income to Company	16,952	18,834	13,883	7,153	1,700	4,424
Minority Interest in Earnings	24	20	-	-	-	-15
Net Income	16,976	18,854	13,883	7,153	1,700	4,409
Net Income to Common	16,976	18,854	13,883	7,153	1,700	4,409
Net Income Growth	3.73%	35.81%	94.09%	320.76%	-61.44%	-4.32%
Shares Outstanding (Basic)	179	179	179	183	182	182
Shares Outstanding (Diluted)	179	179	179	183	182	182
Shares Change (YoY)	-0.00%	-0.21%	-1.67%	0.08%	-0.04%	0.02%
EPS (Basic)	94.78	105.26	77.34	39.18	9.32	24.20
EPS (Diluted)	94.78	105.26	77.34	39.18	9.32	24.16
EPS Growth	3.74%	36.10%	97.40%	320.39%	-61.42%	-4.35%
Free Cash Flow	-	12,957	8,722	7,028	-1,863	442
Free Cash Flow Per Share	-	72.34	48.59	38.50	-10.21	2.42
Dividend Per Share	3.000	6.000	9.500	5.500	4.500	5.250
Dividend Growth	-45.45%	-36.84%	72.73%	22.22%	-14.29%	-22.22%
Gross Margin	83.16%	84.43%	81.29%	75.84%	69.97%	74.13%
Operating Margin	39.17%	44.27%	39.25%	29.90%	6.34%	23.99%
Profit Margin	38.50%	42.56%	34.69%	26.41%	8.73%	21.44%
Free Cash Flow Margin	-	29.25%	21.79%	25.95%	-9.57%	2.15%
EBITDA	19,761	21,960	17,506	9,669	2,600	6,066
EBITDA Margin	44.82%	49.58%	43.74%	35.70%	13.36%	29.50%
D&A For EBITDA	2,490	2,352	1,800	1,571	1,366	1,133
EBIT	17,271	19,608	15,706	8,098	1,234	4,933
EBIT Margin	39.17%	44.27%	39.25%	29.90%	6.34%	23.99%
Effective Tax Rate	17.70%	17.81%	17.04%	17.01%	15.93%	23.67%
Revenue as Reported	47,639	47,840	41,269	28,117	20,438	21,557
Advertising Expenses	-	-	-	-	326	211

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.